Free Trial

Stratec (ETR:SBS) Shares Up 4.3% - Here's Why

Stratec logo with Medical background

Shares of Stratec SE (ETR:SBS - Get Free Report) traded up 4.3% during mid-day trading on Monday . The company traded as high as €24.80 ($27.56) and last traded at €24.30 ($27.00). 7,754 shares changed hands during mid-day trading, an increase of 24% from the average session volume of 6,253 shares. The stock had previously closed at €23.30 ($25.89).

Stratec Stock Up 4.3%

The business has a 50-day simple moving average of €24.94 and a two-hundred day simple moving average of €29.12. The company has a quick ratio of 1.65, a current ratio of 2.52 and a debt-to-equity ratio of 66.97. The stock has a market capitalization of $291.93 million, a P/E ratio of 29.16, a PEG ratio of 10.43 and a beta of 0.16.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Stratec Right Now?

Before you consider Stratec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.

While Stratec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines